You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Mol. Neurosci., 21 February 2022

Sec. Methods and Model Organisms

Volume 15 - 2022 | https://doi.org/10.3389/fnmol.2022.865110

Corrigendum: Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood

  • 1. CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China

  • 2. University of Chinese Academy of Sciences, Beijing, China

  • 3. Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China

  • 4. School of Nanoscience and Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, China

  • 5. School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, China

Article metrics

View details

1

Citations

1,5k

Views

641

Downloads

In the published article, there was an error regarding the affiliations for Yuxin Guo. As well as having affiliation 1, they should also have “University of Chinese Academy of Sciences, Beijing, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

Alzheimer's disease, blood biomarkers, diagnosis, peptide, peptoid

Citation

Guo Y, Hu Z and Wang Z (2022) Corrigendum: Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood. Front. Mol. Neurosci. 15:865110. doi: 10.3389/fnmol.2022.865110

Received

29 January 2022

Accepted

31 January 2022

Published

21 February 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2022

Updates

Copyright

*Correspondence: Zhiyuan Hu Zihua Wang

This article was submitted to Methods and Model Organisms, a section of the journal Frontiers in Molecular Neuroscience

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics